Ginkgo Bioworks Holdings (DNA) Assets Average (2021 - 2026)
Ginkgo Bioworks Holdings (DNA) posted Assets Average of $1.1 billion for Q1 2026, down 6.76% on a QoQ basis from $1.2 billion in Q4 2025, and down 19.4% year-over-year from $1.3 billion in Q1 2025.
Ginkgo Bioworks Holdings (DNA) Assets Average (2021 - 2026) Analysis & Trends
Ginkgo Bioworks Holdings' Assets Average history runs 6 years deep, the most recent figure standing at $1.1 billion for Q1 2026.
- Quarterly Assets Average fell 19.4% year-over-year to $1.1 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.1 billion (down 19.4% YoY) and the FY2025 annual result came in at $1.2 billion, down 17.93% from the prior year.
- Assets Average was $1.1 billion for Q1 2026 at Ginkgo Bioworks Holdings, down from $1.2 billion in the prior quarter.
- Across five years, Assets Average topped out at $2.5 billion in Q1 2023 and bottomed at $1.1 billion in Q1 2026.
- A 5-year average of $1.7 billion and a median of $1.6 billion in 2024 frame the typical range for Assets Average.
- Annual changes were most pronounced in 2022 — Assets Average surged 71.8% — and 2024, when it slumped 34.49%.
- Ginkgo Bioworks Holdings' Assets Average stood at $2.2 billion in 2022, then slipped by 16.29% to $1.8 billion in 2023, then retreated by 22.57% to $1.4 billion in 2024, then declined by 19.22% to $1.2 billion in 2025, then dropped by 6.76% to $1.1 billion in 2026.
- Business Quant data shows DNA's Assets Average at $1.1 billion in Q1 2026, $1.2 billion in Q4 2025, and $1.2 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 303.40 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 65.01 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 8.37 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 41.64 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 26.06 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 40.71 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 795.91 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 2.30 Bn |
| 10 | Ginkgo Bioworks Holdings | 517.16 Mn | 373.30 Mn | 16.38 Mn | 1.08 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.08 Bn |
| Dec 31, 2025 | 1.15 Bn |
| Sep 30, 2025 | 1.21 Bn |
| Jun 30, 2025 | 1.26 Bn |
| Mar 31, 2025 | 1.34 Bn |
| Dec 31, 2024 | 1.43 Bn |
| Sep 30, 2024 | 1.55 Bn |
| Jun 30, 2024 | 1.60 Bn |
| Mar 31, 2024 | 1.62 Bn |
| Dec 31, 2023 | 1.85 Bn |
| Sep 30, 2023 | 2.16 Bn |
| Jun 30, 2023 | 2.35 Bn |
| Mar 31, 2023 | 2.48 Bn |
| Dec 31, 2022 | 2.21 Bn |
| Sep 30, 2022 | 1.93 Bn |
| Jun 30, 2022 | 2.03 Bn |
| Mar 31, 2022 | 2.06 Bn |
| Dec 31, 2021 | 2.11 Bn |
| Sep 30, 2021 | 1.94 Bn |
| Jun 30, 2021 | 1.73 Bn |